Midtown-based drug discovery startup GRIN Therapeutics has reached a deal with Angelini Pharma to commercialize its signature ...

Angelini is paying $50 million upfront for ex-North American rights to radiprodil, with another $520 million in the offing in ...

It is the most common type of epilepsy. Antiseizure medication is usually prescribed for people with the condition. However, for one in three people with epilepsy (around 20 million individuals ...

The Minister for Health has been urged to commence a long-awaited inquiry into the historical prescribing of an anti-epilepsy ...

An anti-seizure medication that epilepsy patients have been asking the Saskatchewan government to pay for is now being covered in the province. Xcopri, the brand name for cenobamate tablets ...

Consultant in epilepsy at the trust Dr Archana Desurkar ... She added that it could take several years before the trial drug became a part of standard NHS treatment due to the rigorous data ...